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Mycobacterium bovis is an intracellular pathogen that causes tuberculosis in cattle. Follow-
ing infection, the pathogen resides and persists inside host macrophages by subverting
host immune responses via a diverse range of mechanisms. Here, a high-density bovine
microarray platform was used to examine the bovine monocyte-derived macrophage tran-
scriptome response to M. bovis infection relative to infection with the attenuated vaccine
strain, M. bovis Bacille Calmette–Guérin. Differentially expressed genes were identified
(adjusted P -value ≤0.01) and interaction networks generated across an infection time
course of 2, 6, and 24 h. The largest number of biological interactions was observed in
the 24-h network, which exhibited scale-free network properties. The 24-h network fea-
tured a small number of key hub and bottleneck gene nodes, including IKBKE, MYC, NFKB1,
and EGR1 that differentiated the macrophage response to virulent and attenuated M. bovis
strains, possibly via the modulation of host cell death mechanisms. These hub and bottle-
neck genes represent possible targets for immuno-modulation of host macrophages by
virulent mycobacterial species that enable their survival within a hostile environment.
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INTRODUCTION
Mycobacterium bovis, the causative agent of bovine tuberculosis
(BTB) is a facultative pathogen that has a genome sequence 99.95%
identical to that of M. tuberculosis, the etiological agent respon-
sible for human tuberculosis (TB) (1). The pathogenesis of BTB
is broadly similar to that of human TB and many of the charac-
teristics of M. tuberculosis infection are thought to apply to M.
bovis infection in cattle (2, 3). Both pathogens enter the host prin-
cipally via inhalation of infected aerosol droplets, where they are
phagocytosed by alveolar macrophages and dendritic cells. Path-
ogenic mycobacteria have evolved mechanisms for subverting the
host immune response, including prevention of phagosome mat-
uration and subsequent lysosomal delivery (4), enabling survival
and replication within the host macrophage following phagocyto-
sis (5). Infected alveolar macrophages can then remain within the
central core of granulomas during latent infection or disseminate
to draining lymph nodes and to other host organs during active
infection (6, 7).
Mycobacterium bovis Bacille Calmette–Guérin (BCG) is an
attenuated strain of M. bovis that has been used as a live vaccine for
TB control for almost a century. It is estimated that over 100 mil-
lion people are immunized with BCG annually, making it the most
widely used vaccine in human populations (8). All BCG strains
available today are derived from a virulent M. bovis strain that was
isolated at the turn of the twentieth century from the milk of an
infected cow with tubercular mastitis (9). This strain, named “lait
Nocard,” was transferred to the Institut Pasteur in Lille in 1901,
where it was cultured on glycerol-soaked potato slices supple-
mented with ox bile by Albert Calmette and Camille Guérin as part
of their studies of TB pathogenesis. Serial passage of the lait Nocard
strain on this culture medium resulted in the isolation of a strain,
in 1908, that displayed reduced virulence in guinea pigs and calves
(9). Over the next 13 years, Calmette and Guérin performed 230
in vitro serial passages of this partially attenuated M. bovis strain,
eventually leading to the first successful vaccination of a human
infant with a fully attenuated BCG isolate in July 1921 (10, 11).
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All currently existing BCG substrains originate from the initial
attenuated strain developed by Calmette and Guérin during this
13-year period. It was during this time that BCG underwent the
first of two attenuation phases. Early studies identified a region of
difference 1 (RD1) that is deleted from all BCG strains (12, 13)
and was likely lost during the initial attenuation phase between
1908 and 1921. RD1 encodes, among other genes, the early secre-
tory antigen target (ESAT-6) protein secretion system (ESX-1),
which is present in virulent strains of M. bovis and M. tuberculo-
sis (14, 15). A second attenuation phase occurred after 1924 due
to dissemination of the BCG vaccine from the Institut Pasteur to
other countries (13). During this time further genomic deletions
occurred, including the RD2 deletion (8, 9).
Virulent M. bovis and attenuated BCG differ in their ability to
generate disease. Infection with M. bovis can lead to subversion
of the host immune response and formation of tuberculous gran-
ulomas with characteristic BTB pathology (16). In contrast, the
BCG vaccine strain does not generally cause progressive infection
in immune-competent hosts, but can induce a protective pro-
inflammatory TH1 response via activation of interferon-gamma
(IFN-γ) secreting CD4+ T-cells (17); however, the precise mech-
anisms of how protection is afforded against virulent challenge
remain unclear.
Despite decades of research, the host innate immune mecha-
nisms elicited following infection with virulent M. bovis relative to
attenuated BCG remain largely unknown. To our knowledge, a sys-
tems biology approach to understanding innate immune responses
to virulent M. bovis and attenuated BCG has not previously been
described. Systems analysis of transcriptomics data generated from
host macrophages infected with the two strains enables recon-
struction of dynamic molecular interaction networks that capture
the differential innate immune responses to virulent M. bovis and
attenuated BCG (18). Network features such as hub and bottle-
neck genes – a consequence of scale-free behavior – can also be
defined, cataloged, and further explored to identify novel bio-
logical attributes relevant to the pathogenesis of mycobacterial
infections.
Previous studies have demonstrated that the bovine monocyte-
derived macrophage (MDM) is a useful model cell type for
understanding the early host immunogenetic response to M. bovis
and M. bovis-derived antigens (19–22). In the present study,
the Affymetrix® GeneChip® Bovine Genome Array was used to
examine the transcriptome of MDM from seven age-matched
Holstein-Friesian female cattle infected in vitro with M. bovis and
BCG across an infection time course of 2, 6, and 24 h. Differ-
entially expressed (DE) genes were identified using established
methods and a list of interactions were generated using the Innat-
eDB resource (23) and visualized as interaction networks with the
Cytoscape software package (24).
MATERIALS AND METHODS
ETHICS STATEMENT
All animal procedures were carried out according to the provi-
sions of the Cruelty to Animals Act (Irish Department of Health
and Children license number B100/3939) and ethical approval for
the study was obtained from the UCD Animal Ethics Committee
(protocol number AREC-P-07-25-MacHugh).
ANIMALS
Seven age-matched (3-year-old) unrelated Holstein-Friesian
females were used in this study. All animals were maintained
under uniform housing conditions and nutritional regimens at the
UCD Lyons Research Farm (Newcastle, County Kildare, Ireland).
The animals were selected from an experimental herd without a
recent history of BTB infection and all animals tested negative for
the single intradermal tuberculin test (SICTT). These cattle were
also negative for infection with Brucella abortus, M. avium subsp.
paratuberculosis, Salmonella Typhimurium, bovine herpesvirus 1
(BHV-1), and bovine viral diarrhea (BVD) virus.
MONOCYTE EXTRACTION AND CULTURE OF MDM
Monocyte extraction and culture of bovine MDM was performed
as described by us previously (20). Briefly, for monocyte isola-
tion, 300 ml of whole blood was collected in acid citrate dextrose
buffer (Sigma-Aldrich Ireland Ltd., Dublin, Ireland) in sterile
bottles. Blood was layered onto Accuspin™ tubes containing
Histopaque® 1077 (Sigma-Aldrich Ireland Ltd., Dublin, Ireland),
and following density gradient centrifugation (500 g for 20 min)
performed at room temperature, peripheral blood mononuclear
cells (PBMC) were collected. Contaminating red blood cells (RBC)
were removed following resuspension and subsequent incubation
of the PBMC in RBC lysis buffer (10 mM KHCO3, 150 mM NH4Cl,
0.1 mM EDTA pH 8.0) for 5 min at room temperature. After incu-
bation, PBMC were washed twice with sterile phosphate-buffered
saline (PBS; Invitrogen™, Life Technologies Corporation, Pais-
ley, UK) before resuspending cells in PBS containing 1% bovine
serum albumin (BSA; Sigma-Aldrich Ireland Ltd., Dublin, Ire-
land). Monocytes were then isolated using the MACS® protocol
and MACSH MicroBeads conjugated to mouse anti-human CD14
antibodies (Miltenyi Biotec Ltd., Surrey, UK), which has been
shown to be cross-reactive with bovine monocytes (25). The
MACS® protocol was performed according to the manufacturer’s
instructions.
The identity and purity of monocytes was confirmed by flow
cytometry using an anti-CD14 fluorescein-labeled antibody (data
not shown). This method has been previously shown by us to
yield a purity of CD14+ cells ≥99% (19). Purified monocytes
were seeded at 1× 106 per well on 24-well tissue culture plates
in RPMI 1640 medium (Invitrogen™, Life Technologies Corpo-
ration, Paisley, UK) containing 15% heat inactivated fetal calf
serum (FCS; Sigma-Aldrich Ireland Ltd., Dublin, Ireland), 1%
non-essential amino acids (NEAA; Sigma-Aldrich Ireland Ltd.,
Dublin, Ireland), gentamicin (5 mg/ml; Sigma-Aldrich Ireland
Ltd., Dublin, Ireland), and incubated at 37°C, 5% CO2. Following
24 h incubation (day one), the media was replaced with 1 ml fresh
antibiotic-containing media to remove any non-adhered cells. On
day three, media was replaced with 1 ml antibiotic-free culture
media (RPMI 1640 medium containing 15% heat inactivated FCS
and 1% NEAA only). To ensure that the same number of MDM
were subjected to mycobacterial challenge, cells were dissociated
on day five using 1× non-enzymatic cell dissociation solution
(Sigma-Aldrich Ireland Ltd., Dublin, Ireland), counted, and then
re-seeded at 2× 105 cells per well in 24-well tissue culture plates
(Sarstedt Ltd., County Wexford, Ireland) using antibiotic-free cul-
ture media. By day eight, 80–100% confluent monolayers of MDM
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were generated that displayed the characteristic macrophage mor-
phology as confirmed by Giemsa staining (data not shown). On
day eight, MDM were used for the in vitro challenge experiments
with M. bovis and M. bovis BCG.
CULTURE OF M. BOVIS AND BCG AND INFECTION OF BOVINE MDM
The culturing of M. bovis (strain M2137; spoligotype SB0142)
has been described by us previously (20). Culturing of BCG (Pas-
teur strain) was performed in a Biosafety Containment Level 3
(CL3) laboratory and conformed to the national guidelines on
the use of Hazard Group 3 infectious organisms. BCG stocks
for the in vitro MDM infection experiments were cultured in
Middlebrook 7H9 medium (Difco™, Becton, Dickinson Ltd.,
Oxford, UK) containing 10% (vol/vol) BBL™ Middlebrook
OADC Enrichment (Difco™, Becton, Dickinson Ltd., Oxford,
UK), 0.05% Tween 80 (Sigma-Aldrich, Dublin, Ireland), and
0.50% (weight/vol) glycerol (Sigma-Aldrich Ltd., Dublin, Ire-
land) at 37°C. Bacterial cultures were grown to mid-logarithmic
phase as determined by spectrophotometric analysis prior to the
challenge experiments using the purified bovine MDM. Colony-
forming unit (cfu) counting was performed using Middlebrook
7H11 medium (Difco™, Becton-Dickinson Ltd., Dublin, Ireland)
containing 10% (vol/vol) Middlebrook (ADC) enrichment (Dif-
co™, Becton-Dickinson Ltd., Dublin, Ireland) and 0.50% (vol/vol)
glycerol (Sigma-Aldrich, Dublin, Ireland).
Monocyte-derived macrophage infections with BCG were per-
formed as previously described for MDM infections with M. bovis
(20). In brief, MDM (seeded at 2× 105 cells per well) were chal-
lenged with BCG (4× 105 cells per well) prepared in antibiotic-free
culture media (RPMI 1640 medium containing 15% heat inacti-
vated FCS and 1% NEAA only). BCG cell counts were performed
using a Petroff Hausser chamber (Fisher Scientific Ltd., Dublin,
Ireland) following sterile filtering to prevent clumping using a
5µm filter (Millipore Ireland Ltd., County Cork, Ireland). BCG
cell numbers were then adjusted and 4× 105 bacilli were added to
the appropriate wells giving a multiplicity of infection (MOI) of
2:1. Subsequent cfu for BCG counting also yielded a mean MOI
of 2:1. Once challenged, MDM were incubated at 37°C, 5% CO2
for 2, 6, and 24 h.
RNA EXTRACTION AND MICROARRAY ANALYSIS
RNA extraction and microarray analysis has been described by
us previously (20). Briefly, global gene expression was analyzed
using the pan-genomic high-density Affymetrix® GeneChip®
Bovine Genome Array (Affymetrix UK Ltd., High Wycombe,
UK1). This array contains 24,072 probe sets representing over
23,000 gene transcripts and includes approximately 19,000 Uni-
Gene clusters. cDNA labeling, hybridization, and scanning for the
microarray experiments were performed by Almac Diagnostics
Ltd. (Craigavon, Co. Armagh, Northern Ireland) using a one-cycle
amplification/labeling protocol.
STATISTICAL ANALYSIS OF MICROARRAY DATA
Affymetrix® GeneChip® Bovine Genome Array data were ana-
lyzed using BioConductor (26)2 contained within the R statistical
1www.affymetrix.com
2www.bioconductor.org
package3. All raw data were normalized using the factor analy-
sis for robust microarray summarization (FARMS) package. The
FARMS package uses only perfect match (PM) probes and a quan-
tile normalization procedure, providing both P-values and signal
intensities (27). Normalized data were then further subjected to
filtering for informative probes sets using the I/NI-calls package
in R (28). This defines a probe set as being informative when
many of its probes reflect the same change in mRNA concentra-
tion across arrays. DE genes for a paired comparison between M.
bovis versus BCG infections at each time point were extracted
using a moderated paired t -test within the Linear Models for
Microarray Data (LIMMA) R package (29)4. Genes displaying dif-
ferential expression were annotated using the Affymetrix® bovine
gene annotation. The Benjamini–Hochberg multiple-testing cor-
rection method (30) was applied to all DE genes to minimize the
false discovery rate (FDR) and adjusted P-values for all DE genes
were calculated. Only DE genes with an adjusted P-value of ≤0.01
were used for subsequent network reconstruction and analysis. All
data are MIAME compliant and have been submitted to the NCBI
gene expression omnibus (GEO) database with experiment series
accession number GSE59774.
GENERATION OF InnateDB INTERACTION LISTS
Affymetrix® probe IDs for the DE gene lists at each time point
were mapped to human Ensembl IDs, using the BioMart search
tool on the Ensembl genome database5. Each of the three DE gene
lists were uploaded separately to the InnateDB6 curated, inter-
action database (23), where a list of interactions between the
uploaded molecules were generated. At the time of this analy-
sis, the InnateDB resource contained over 195,000 experimentally
determined interactions, of which more than 18,000 have been
manually curated, allowing for a detailed systems-level analysis of
the innate immune response. The interactions, for each time point,
were then viewed as a reconstructed network using the Cytoscape
software (24)7. Small clusters of nodes that did not connect to the
main network were removed from the analysis.
24 h INTERACTION NETWORK ANALYSIS
The 24-h interaction network was analyzed as an undirected,
Markov, network. Statistical analysis of the network was per-
formed using the NetworkAnalyzer plugin of Cytoscape (31). Hub
nodes were identified by calculating the degree of connectivity
(DOC) for each node in the network using the Degree Sorted Circle
Layout in Cytoscape. DOC is a measure of the number of inter-
actions a node has within the network. Nodes with the highest
DOC are classed as hub nodes. Bottleneck nodes were identified
by calculating the betweenness centrality index (BCI) for each
node in the network, also using the NetworkAnalyzer plugin. BCI
is a measure of how often a node appears on the shortest path
between nodes in the network and is a reflection of the amount of
control a node exerts over the interactions of other nodes in the
3www.r-project.org
4www.bioconductor.org/packages/release/bioc/html/limma.html
5www.ensembl.org/biomart/martview
6www.innatedb.com
7www.cytoscape.org
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network (32). A Spearman rank correlation between the DOC and
log2 fold-change in gene expression (M. bovis-infected MDM rel-
ative to BCG-infected MDM) was performed in the SPSS statistics
version 20 package (IBM, New York, NY, USA).
Combination of interactions and differentially expressed gene lists
Several Perl scripts were implemented to combine gene lists and
interactions in various ways. One was used to calculate the num-
bers of genes that are DE and linked to a set of hub genes by
a certain distance of edges/interactions, another one to extract
expression values for interactors with bottleneck genes at all
time points. All scripts are available through GitHub at: https:
//github.com/kkillick/Systems-biology-paper.git.
Gene ontology of 24 h network
Ingenuity® systems pathway analysis (IPA) was used to identify
gene ontology (GO) functional categories over-represented within
the DE genes found in the 24-h interaction network. The Inge-
nuity® knowledge base contains the largest database of manually
curated and experimentally validated physical, transcriptional, and
enzymatic molecular interactions. Furthermore, each interaction
in the Ingenuity® knowledge base is supported by previously pub-
lished information. For IPA GO analysis, the Ingenuity® knowl-
edge base was used as a reference set and only genes within the
24-h interaction network were uploaded. IPA then performed an
over-representation analysis that categorized the DE genes within
the uploaded list into functional GO categories. Each GO category
in IPA is ranked based on the number of DE genes falling into
each functional group. Right-tailed Fisher’s exact tests were used
to calculate an overlap P-value for each of the biological functions
assigned to the list of DE genes.
Expression analysis of the interactors of the top hub and bottleneck
genes
The top hub and bottleneck genes (IKBKE, MYC, NFKB1, and
EGR1) were specified in InnateDB to generate lists of all human
interactions. DE genes for a paired comparison of M. bovis versus
BCG infections at each time point, using an adjusted P-value of
≤0.01, were extracted from the complete interaction lists and visu-
alized using the Circos software package8 (33). Interaction nodes
colored in red indicate that the gene was up-regulated within the
dataset, while green indicate that the gene was down-regulated.
Identification of scale-free and small-world properties within the
24-h network
If a network has a node degree distribution that can be fitted
with a power law distribution, it can be a sign that the network
has a scale-free architecture. Node degree distribution of the 24-
h network was calculated using the NetworkAnalyzer plugin of
cytoscape and a power law distribution was fitted using Microsoft
Excel.
To determine whether a network displays small-world proper-
ties it must show L>˜Lrandom but C  Crandom. Where L is the
characteristic path length, defined as the number of edges in the
8http://circos.ca
shortest path between two nodes, averaged over all pairs of nodes,
and C, the clustering coefficient, is defined as follows: node n has
kn max number of edges. Cn denotes the fraction of these edges
that actually exist, while C is defined at the average of Cn over
all n (34).
The R package igraph9 was used to generate 1,000 random
networks, each with 716 nodes and 1,785 edges. The mean char-
acteristic path length and the mean clustering coefficient were
calculated across the 1,000 networks also using the average path
length and transitivity functions of the igraph R package. All R
code used here is available through GitHub at: https://github.com/
kkillick/Systems-biology-paper.git.
REAL TIME QUANTITATIVE REVERSE TRANSCRIPTION (qRT)-PCR
VALIDATION OF MICROARRAY RESULTS
A panel of 12 genes that were DE across all three time points
based on the microarray data was selected for microarray val-
idation using real time quantitative reverse transcription PCR
(qRT-PCR) analysis. The laboratory and statistical methods used
to perform this analysis are described in Section “Real Time
Quantitative Reverse Transcription (qRT)-PCR Validation of
Microarray Results” in Supplementary Material, and Table S1 in
Supplementary Material details the qRT-PCR primers used in
this study.
RESULTS
INCREASING DIFFERENTIAL GENE EXPRESSION BETWEEN M. BOVIS -
VERSUS BCG-INFECTED MDM OVER TIME
Comparison of gene expression profiles between paired M. bovis
versus BCG in vitro infections revealed 702 DE genes at 2 h and
1,000 and 2,674 DE genes at 6 and 24 h post-infection, respec-
tively (adjusted P-value≤0.01). Of the 702 DE genes found at the
2-h time point, 334 genes displayed increased expression in M.
bovis infections relative to BCG infections (hereafter referred to
as up-regulated), while 368 genes showed decreased expression in
M. bovis infections relative to BCG infections (hereafter referred
to as down-regulated). At the 6-h time point, 569 genes were up-
regulated, with 431 genes displaying down-regulation, while at
the 24-h time point 1,152 and 1,522 genes were up- and down-
regulated, respectively. Tables S2–S4 in Supplementary Material
contain DE gene results for the 2, 6, and 24 h post-infection time
points, respectively. Figure 1 depicts the number of DE genes and
the relative change in expression across the infection time course.
InnateDB INTERACTION ANALYSES
InnateDB is an open-source database containing experimentally
verified gene and protein-interactions involved in the human,
mouse, and bovine innate immune response (23). As a larger
number of curated interactions are available for human data, the
DE genes detected here were mapped to corresponding human
Ensembl gene IDs prior to analysis with InnateDB. In total, 362
DE genes at 2 h, 554 DE genes at 6 h, and 1,503 DE genes at
24 h mapped to human Ensembl gene IDs. These gene lists were
examined separately using InnateDB to generate a catalog of inter-
actions for each infection time point. At 2 h post-infection, 205
9http://igraph.sourceforge.net/doc/R/igraph.pdf
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FIGURE 1 | Number of DE genes found for a paired comparison of
virulent M. bovis versus attenuated BCG infections of bovine MDM
(n=7) across a time course of 2, 6, and 24 h post-infection. DE gene
numbers are reported here after filtering using an adjusted P -value of ≤0.01.
Red bars indicate the number of genes displaying increased relative
expression in M. bovis compared to BCG (up-regulated) and green bars
indicate the number of genes displaying decreased relative expression in
M. bovis compared to BCG (down-regulated).
interactions were identified, while 413 and 1,785 interactions were
detected for 6 and 24 h, respectively. As the 24-h time point gen-
erated the largest interaction network, it was chosen for detailed
downstream analyses.
24 h INTERACTION NETWORK RECONSTRUCTION AND ANALYSIS
Removal of small groups of nodes not linked to the main clus-
ter left 615 nodes for analysis in the 24-h interaction network.
These were connected via 1,670 edges. Two hundred eight of these
nodes had self-interaction loops. The network diameter was 10
and the average shortest path length was 4.315. The IKBKE, MYC,
NFKB1, HDAC5, and TRAF2 genes were identified as the top hub
nodes within the network. A degree of connectivity (DOC) of
57 was found for IKBKE, 57 for MYC, 55 for NFKB1, 52 for
HDAC5, and 50 for TRAF2. The DOC for these five nodes was
markedly higher than the mean number of connections found for
nodes within the network of 3.857, suggesting that they are hub
genes within the 24-h network. Also, for the 24-h interaction net-
work, IKBKE, MYC, and EGR1 displayed the highest betweenness
centrality index (BCI) of 0.1661, 0.1360, and 0.1297, respectively
(Figure S1 in Supplementary Material). This finding suggests that
IKBKE, MYC, and EGR1 are also key bottleneck nodes within the
24-h interaction network.
No significant correlation between the DOC and the log2 fold-
change in gene expression for nodes was found, indicating that
nodes with the greatest changes in expression between groups
may not have the biggest influence on other nodes within the net-
work (Spearman rho value 0.066, P = 0.108) (Figure 2). Figures S2
and S3 in Supplementary Material show the biological interaction
networks for the 2 and 6-h infection time points, respectively.
SCALE-FREE AND SMALL-WORLD PROPERTIES OF THE M. BOVIS
VERSUS BCG 24 h INTERACTION NETWORK
A power law distribution was fitted to the node degree distribution
of the 24-h network, generating an R2 value of 0.867 (Figure S4 in
Supplementary Material). This result suggests that the 24-h inter-
action network has a scale-free architecture, whereby many nodes
have a small number of connections yet a small number of hub
nodes have many connections. Scale-free networks tend to exhibit
the small-world network property of high clustering and short
average path lengths, L>˜ Lrandom but CCrandom, (where L is the
characteristic path length and C is the clustering coefficient) (34).
This was tested on the 24-h interaction network by comparing it
to 1,000 random networks generated with the igraph R package
using the same number of nodes and edges. The random net-
works yielded a mean C = 0.007, with a maximum C = 0.012 and
L= 4.251. Conversely, for the observed 24 h interaction network,
the C and L values were 0.112 and 4.315, respectively. With a C
value 15.9-fold higher than the mean C value for the 1,000 ran-
dom networks, and the L value only marginally higher, the 24-h
interaction network exhibits small-world properties.
Highlighting the gene neighborhoods at increasing distances
from a main hub node (MYC) in the 24-h interaction network
demonstrates the scale-free architecture of the network. Figure 3
shows that almost all other nodes in the network (587 out of 615)
are connected to MYC through less than five edges. The com-
bined effect of the three main hub gene nodes (IKBKE, MYC,
and NFKB1) is presented in Figure 4A. It shows that nearly all
DE genes in the network (96%) are linked through a maximum
of four edges to one of the three key hub genes. This is signifi-
cantly higher than expected by chance (P-value< 0.01), based on
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FIGURE 2 |Top 30 gene nodes in the 24-h interaction network that displayed the highest DOC (red line). The log2 fold-change values for these genes are
also shown (blue line).
100,000 permutation tests. In addition, the intersection between
the linked genes from all hubs rises quickly from less than 10% at
a distance of two edges to nearly 90% at a distance of four edges
(Figure 4B), indicating complex intertwinement and a capacity
for rapid dissemination of signals throughout the network.
GENE ONTOLOGY OF THE M. BOVIS VERSUS BCG 24 h INTERACTION
NETWORK
The total number of DE genes that could be mapped to mole-
cules in the Ingenuity® Knowledge Base was 507, out of the 615
genes in the uploaded dataset. GO analysis facilitates discovery
of molecular functions that are enriched within a dataset. IPA
GO analysis of molecules within the 24-h interaction network
revealed Cell death to be a major over-represented functional cat-
egory. Two hundred thirty-seven of the molecules within the 24-h
network were involved in Cell death and an adjusted P-value of
4.18× 10−25 was obtained for this category. Further inspection
showed that the top 15 hub nodes and the top 15 bottleneck nodes
were also involved in the Cell death GO category.
EXPRESSION ANALYSIS OF THE INTERACTORS OF THE TOP HUB AND
BOTTLENECK GENES
Expression changes of the interactors with the top hub and bot-
tleneck genes IKBKE, NFKB1, MYC, and EGR1 were examined at
each of the three time points. Using an adjusted P-value of ≤0.01,
it was observed that the majority of the interactors were DE at
24 h for a paired comparison of M. bovis versus BCG infections.
This is in contrast to the earlier time points where only small
numbers of interactors exhibited significant expression changes
(adjusted P-value ≤0.01). For example, the number of DE genes
that interact with IKBKE increased from 6 to 12 between time
points 2 and 6 h, but expanded to 68 at 24 h. These results suggest
that differential regulatory activity at the IKBKE hub gene and its
interactors increases over time in MDM infected with M. bovis
relative to BCG. A similar outcome was observed for the NFKB1
and MYC hub genes and the EGR1 hub/bottleneck gene, where the
equivalent numbers of DE genes for the 2, 6, and 24-h time points
were 19, 27, and 42; 15, 22, and 72; and 23, 26 and 54, respectively
(Figure 5).
REAL TIME QUANTITATIVE REVERSE TRANSCRIPTION PCR (qRT-PCR)
VALIDATION OF MICROARRAY RESULTS
The results from real time qRT-PCR validation of the microarray
results are provided in Table S5 in Supplementary Material.
DISCUSSION
The ability of pathogenic mycobacteria to cause disease has been
largely attributed to their capacity to survive and replicate in
macrophages via a diverse range of mechanisms that subvert the
host innate immune response (35). It is believed that mycobac-
terial virulence is, in part, governed by several secreted virulence
factors, such as members of the ESAT-6 protein family encoded
by the RD1 genome region. Notably, the RD1 region is present
in all virulent M. tuberculosis and M. bovis strains and is one
of several regions of difference deleted from the genome of all
strains of attenuated BCG (36). The presence or absence of these
virulence factors are thought to result in differential host innate
immune responses to virulent and attenuated mycobacteria that
can be identified through the analysis of host gene expression data
(37–39). In the present study, we have analyzed the global differ-
ential bovine macrophage transcriptional response to virulent M.
bovis and attenuated BCG across an in vitro infection time course
of 2, 6, and 24 h. Furthermore, we have applied a systems biol-
ogy approach to reconstruct the complex molecular interactions
and networks that illustrate the differential macrophage responses
to these mycobacterial strains. Further work will be necessary to
provide insights into whether key genes identified in this study
represent aspects of attenuation regulated by the RD1 region.
Comparison of the MDM response to infection with M. bovis
relative to BCG revealed the largest number of DE genes at
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FIGURE 3 |The 24-h interaction network demonstrating scale-free
network properties. The main hub gene node, MYC, is shown in black.
Gene nodes that are one edge/interaction from MYC are colored purple;
gene nodes that are two edges/interactions from MYC are colored red;
gene nodes that are three edges/interactions from MYC are colored
orange; and gene nodes that are four edges/interactions from MYC are
colored yellow. Gene nodes colored gray are greater than four
edges/interactions from MYC.
24 h post-infection (2,674 DE genes), which was 3.8- and 2.7-
fold higher than the number of DE genes at the observed at 2 h
(702 DE genes) and 6 h time points (1,000 DE genes), respec-
tively (Figure 1). Notably, comparison between M. bovis- and
BCG-infected MDM at the 2-h time point did not reveal signifi-
cant differences in the expression profiles of key immune-related
genes known to be important during mycobacterial infection.
For example, mRNA transcripts were detected for genes encod-
ing macrophage pattern recognition receptors (PRRs) such as
TLR2 and TLR4, which are involved in the recognition of
evolutionarily conserved pathogen-associated molecular patterns
(PAMPs), and inflammatory cytokines including IL1B, IL6, and
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FIGURE 4 | Numbers of DE genes linked to at least one of the three key
hub genes (IKBKE, MYC, and NFKB1) up to a certain distance in terms of
edges/interactions. (A) Union of genes linked to the hubs and median
average of 100,000 permutations, including 95% of the distribution.
(B) Intersection of genes linked to the hubs and median average of 100,000
permutations, including 95% of the distribution.
IL10 following infection; however, these were not DE between
treatments (adjusted P-value of 0.01).
Systems analysis of the DE genes identified at the 24-h time
point generated a biological interaction network that displayed
both scale-free and small-world properties (Figure 3). In a scale-
free network, nodes are highly clustered and can be connected to
each other by relatively few steps due, in part, to the presence of a
small number of highly connected hub nodes (34, 40). Hub nodes,
identified as those nodes that have the highest DOC within a net-
work, enable scale-free networks to be highly robust. The majority
of nodes in the network are non-hub nodes with only a small
number of connections; therefore, scale-free networks can with-
stand the removal of non-hub nodes and still retain the capacity
to transmit information across the whole network. As such, these
networks are said to be “error tolerant.” There are many examples
of both small-world and scale-free networks, including metabolic
networks (41–43), neural networks in the brain (44, 45), and the
Internet (46). However, scale-free networks are vulnerable: should
key hub nodes be removed, the network will be seriously compro-
mised. Therefore, although scale-free and small-world networks
are highly robust against random removal of non-hub nodes, they
are vulnerable to targeted attacks on key hub nodes (47).
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FIGURE 5 | All interactions within InnateDB for the IKBKE, MYC, and
NFKB1 hub genes plus the top bottleneck gene node (EGR1) that show
significantly differential expression in at least one of the three time
points using an adjusted P -value of ≤0.01. Color intensity indicates the
degree of up-regulation (red) or down-regulation (green) in the M. bovis-
versus the BCG-infected bovine MDM (n=7) at each time point.
In the current study, IKBKE, MYC, and NFKB1 were the top
three ranking hub genes within the 24-h network (Figure 2).
The importance of these genes is highlighted by the effect they
have on the network based on the number of DE genes that are
close neighbors (up to four edges away, Figure 4). There is not
enough information available from the interaction databases to
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infer directionality for all interactions in the network, but the type
of products associated with these hubs (inhibitors and activators,
see below) suggest that most of their interactors lie downstream
within a signaling cascade. The fact that nearly all of the DE genes
in the network are linked by a maximum of four edges to one of the
three main hub genes emphasizes the rapid and extensive response
that can be initiated by change of expression in a very small num-
ber of genes. Furthermore, although the first- and second-degree
DE neighbors of the hubs are mostly separate sub-groups, these
sets of genes merge quickly into one large group after the next two
extensions of the network. In other words, the overall number of
DE genes (but not necessarily the type of expression change) could
potentially be derived from changes at any one of the hubs, which
points toward a single response captured by the network, com-
pared to a group of separate responses. This correlates well with the
detection of one common category (Cell death) found to be signif-
icantly over-represented in the GO analysis; however, observable
differences in macrophage viability or morphology between BCG
and M. bovis infections were not examined. The identification of
three hubs instead of just one could be indicative of (i) redundancy,
which has evolved for more robustness in the response to infec-
tions; or (ii) fine-tuning derived from interplay between different
regulators, which could provide greater control of the response.
The products of the IKBKE and NFKB1 genes are central
to the NF-κB signaling pathway that regulates the expression of
many immune-related genes following infection. IKBKE encodes
a subunit of the inhibitor of κB (IκB) kinase (IKK) complex,
which phosphorylates the NF-κB inhibitors (IKBs), resulting in
the release of the NF-κB transcription factor complex, a subunit
of which is encoded by the NFKB1 gene (48). Notably, at the 24-
h time point, both IKBKE and NFKB1 were up-regulated in the
M. bovis-infected MDM relative to BCG-infected MDM, suggest-
ing that there is increased activation of NF-κB signaling following
infection with the virulent mycobacterial strain. This is further
supported by the increased relative expression of several NF-κB-
inducible genes known to play a role in the host response to M.
bovis, such as IL1A, IL1B, IL6, and TNF (49–51).
The up-regulation of the IKBKE and NFKB1 hub genes indi-
cates that activation of NF-κB and consequent downstream sig-
naling and interactors of these hub genes (Figure 5) are crucial for
the differential success of virulent and attenuated M. bovis strains
within the host macrophage. Indeed, several pathogens, including
Helicobacter pylori and Chlamydia pneumoniae, have been shown
to manipulate the host NF-κB signaling pathway to ensure their
survival (52). Evidence of the modulation of monocyte NF-κB
signaling following mycobacterial infection has also been demon-
strated. Dhiman et al. (53) showed that human monocytes infected
with virulent M. tuberculosis exhibited increased NF-κB activity
that resulted in up-regulation of NF-κB-inducible anti-apoptotic
genes and increased survival relative to monocytes infected with
avirulent M. tuberculosis. In the current study, we also observed
increased expression of several NF-κB-inducible anti-apoptotic
genes including BIRC3, CFLAR, and TRAF2, which were among
the downstream interactors of the IKBKE and NFKB1 hub genes
(Figure 5). Furthermore, GO analysis of all nodes in the 24-h net-
work revealed enrichment for genes involved in apoptosis, which
is increasingly regarded as a host innate immune mechanism that
contains and limits mycobacterial growth following infection (54–
56). However, the induction of anti-apoptotic genes may represent
an immuno-modulation strategy employed by the pathogen that
inhibits apoptosis, enabling survival, and replication within the
macrophage (55). Therefore, it is possible that virulent M. bovis
targets key members of the NF-kB pathway causing the induction
of anti-apoptotic mechanisms that result in prolonged viability
within the bovine macrophage.
MYC, another highly connected hub gene identified within the
24-h network, displayed the same DOC as IKBKE. MYC encodes a
multi-functional transcription factor that serves as a key regulator
of cell proliferation and apoptosis and has been shown to suppress
or activate the expression of its target genes (57, 58). A recent study
has shown that MYC expression was induced in primary human
blood-derived macrophages following in vitro infection with path-
ogenic and non-pathogenic mycobacterial species. Moreover, it
was demonstrated that the MYC transcription factor mediated the
suppression of intra-macrophage mycobacterial growth via the
activation of cytokines including TNF and IL-6 (59). In the cur-
rent study, MYC was down-regulated in M. bovis-infected MDM
relative to BCG-infected MDM within the 24-h network. Further-
more, 51 of 73 (69.8%) of the downstream MYC interactors at
the 24-h time point were also down-regulated (Figure 5). Previ-
ous work by our group using the same M. bovis-infected MDM
described here demonstrated that MYC was down-regulated rel-
ative to non-infected MDM from the same animals (20, 22). It is
also important to note that MYC was not DE in the BCG-infected
MDM analyzed here relative to the same control MDM (unpub-
lished results). Collectively, these results suggest that suppression
of MYC following M. bovis infection results in the suppression of
host pro-inflammatory responses leading to intracellular micro-
bial survival and growth. Hence, MYC may serve as a key target
for mycobacterial modulation of innate immune mechanisms,
facilitating persistence within host macrophages.
Bottleneck nodes in the 24-h network were identified as nodes
with a high BCI (Figure S1 in Supplementary Material). BCI has
been shown to be associated with constrained evolutionary rates
for gene or protein nodes in biological networks; studies involving
eukaryote protein-interaction networks have demonstrated that
bottleneck nodes evolve more slowly than non-bottleneck nodes
(60, 61). Analyses of protein-interaction networks have also shown
that bottleneck nodes are more likely to be essential for organismal
survival than non-bottleneck nodes (62, 63).
In the current study, EGR1, together with IKBKE and MYC, was
identified as a top bottleneck node within the 24-h interaction net-
work (Figure S1 in Supplementary Material), with the majority of
significantly DE genes interacting with EGR1 showing changes at
this time point (55 out of 85, Figure 5). EGR1 encodes a zinc-finger
transcription factor that regulates the expression of a large num-
ber of genes involved in cellular differentiation and mitogenesis.
In addition, EGR-1 has also been shown to regulate the transcrip-
tion of pro-inflammatory cytokines in murine macrophages in
response to stimulation with bacterial antigens, including TNF
and IL-6 (64, 65). To our knowledge, only one publication exists
associating EGR1 with mycobacteria–macrophage interactions
(66), although it has recently been identified as part of a con-
served macrophage core transcriptional response module that is
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DE in response to intracellular bacterial pathogens (67). Here,
identification of EGR1 as a key bottleneck gene suggests that this
gene is a component of a differential bovine macrophage response
module to virulent and attenuated mycobacterial strains.
It has been shown that many of the species and subspecies in
the M. tuberculosis complex exhibit specific host association (68).
It is believed that this host specificity is an evolutionary conse-
quence of reciprocal adaptive genetic changes that have occurred
due to strong selection pressures between the interacting path-
ogenic mycobacteria and their hosts (69, 70). Several examples
of reciprocal traits involved in host-mycobacterial pathogen co-
evolution have been described, including the ability of the host
immune system to clear infection versus the ability of virulent
pathogens to subvert and evade host immune responses (71). It is
likely that the small-world properties of the 24-h network reflect
host–pathogen co-evolution. Small-world networks are character-
ized by the presence of hub and bottleneck genes that interact with
all other nodes within the network via a small number of steps.
This model predicts that the expression and products of these hub
and bottleneck genes enable the host to regulate an appropriate and
efficient immune response to virulent or attenuated mycobacterial
strains. Alternatively, key hub and bottleneck genes may serve as
targets for the subversion of host immune responses by virulent
pathogens that underlie successful infection, such as the suppres-
sion of apoptosis-related mechanisms by host transcription factors
as demonstrated by Dyer et al. (72).
At the individual gene level, from the results presented here, it is
not possible to determine whether host macrophage gene expres-
sion changes are due to regulation of host gene networks by the
pathogen, the host, or a combination of both. In this regard, previ-
ous studies have demonstrated that pathogen-encoded protein vir-
ulence factors and, more recently, pathogen-encoded small regu-
latory RNA molecules manipulate and modulate host macrophage
responses to facilitate intracellular survival and dissemination of
pathogenic mycobacteria (73–79). Consequently, to fully under-
stand the complex transcriptional regulatory interplay underlying
host–mycobacterium interactions, it will be necessary to per-
form parallel high-throughput transcriptional profiling of mRNA
and microRNA in both host and microbial cells (80, 81) and
complement these with experimental detection of host–pathogen
molecular interactions (82, 83).
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